Yoshikazu Nishimura

This inventor holds 13 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2001-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshikazu Nishimura. Retrieved from https://idiyas.com/inventor/yoshikazu-nishimura-ct797b99

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 7)

% Patents Active = 84.6

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 9.0

ph-index = 4

Forward Citations = 36(Granted Patents)

Location History:

Shizuoka-ken, JP (2001)
Shizuoka, JP (2004 - 2023)

Company Filing History:

13 out of 987

Chugai Seiyaku Kabushiki Kaisha

patents

Years Active: 2001-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410168 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2025-09-09),

2. 12331050 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2025-06-17),

3. 12331049 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2025-06-17),

4. RE50455 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2025-06-10),

5. 12187724 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2025-01-07),

6. 11814381 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2023-11-14),

7. 10858356 - Pyrazolopyridine derivative having GLP-1 receptor agonist effect (2020-12-08),

8. 9487517 - Spiroimidazolone derivative (2016-11-08),

9. 9428505 - Hydantoin derivative (2016-08-30),

10. 9169254 - Spiroimidazolone derivative (2015-10-27),

11. 7196081 - Compounds with hydroxycarbonyl-halogenoalkyl side chains (2007-03-27),

12. 6737417 - Compounds with hydroxycarbonyl-halogenoalkyl side chain (2004-05-18),

13. 6331553 - Aromatic amine derivatives having NOS inhibiting action (2001-12-18),

Title: Innovations of Yoshikazu Nishimura

Introduction

Yoshikazu Nishimura is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating diabetes and obesity. With a total of 13 patents to his name, his work continues to impact the medical community.

Latest Patents

One of his latest patents includes a pyrazolopyridine derivative that exhibits a GLP-1 receptor agonist effect. This invention provides a compound characterized by a specific structure where the indole ring and the pyrazolopyridine structure are connected through a substituent. The patent also covers salts and solvates of the compound, which serve as preventative or therapeutic agents for non-insulin-dependent diabetes mellitus (Type 2 diabetes) and obesity.

Career Highlights

Yoshikazu Nishimura has been associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His innovative work has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

He has collaborated with notable colleagues such as Masahiro Nishimoto and Yoshiyuki Furuta, contributing to the advancement of research and development in their field.

Conclusion

Yoshikazu Nishimura's contributions to pharmaceutical innovations, particularly in diabetes and obesity treatment, highlight his role as a significant inventor. His ongoing work continues to pave the way for new therapeutic solutions.

Profile summary based on public USPTO records.